CLOs on the Move

Xilio Therapeutics

www.xiliotx.com

 
Xilio is a Waltham, Massachusetts-based biopharmaceutical company focused on defeating cancer. The company`s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.xiliotx.com
  • 828 Winter Street
    Waltham, MA USA 02451
  • Phone: 617.833.1027

Executives

Name Title Contact Details
Christopher Frankenfield
 General Counsel Profile

Similar Companies

Glympse Bio

Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases.

YM BioSciences

YM BioSciences Inc. is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Cell Signaling Technology

Cell Signaling Technology, Inc. is a Danvers, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Okogen

Okogen serves the needs of adults and children with ocular infections by developing therapies to reduce suffering, improve quality of life, and preserve vision.

NexBio

NexBio is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.